Hematologic Oncology Update
Hematologic Oncology Update
✓

Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2026 Annual Meeting

· Mostrar notas
00:59:31
Podcasts
RSS
Link

SOBRE ESTE EPISÓDIO

Featuring perspectives from Dr Meletios-Athanasios (Thanos) C Dimopoulos, Dr Robert Z Orlowski and Dr Noopur Raje, moderated by Dr Orlowski, including the following topics:

  • Introduction (0:00)
  • New and Emerging Strategies with Bispecific Antibodies in Multiple Myeloma (MM) — Dr Raje (2:20)
  • Utility of Antibody-Drug Conjugates for Relapsed/Refractory (R/R) MM — Dr Orlowski (23:33)
  • Potential Role of Cereblon E3 Ligase Modulators and Other Promising Novel Agents and Strategies for R/R MM — Prof Dimopoulos (41:12)

CME information and select publications

Ciência
Medicina
Inglês
Estados Unidos da América
UseAPIpara buscar este episódio emJSON

NESTE EPISÓDIO

Editar estas etiquetas

MOSTRAR NOTAS 🔗

00:00:00Introduction
00:02:20New and Emerging Strategies with Bispecific Antibodies in Multiple Myeloma (MM) — Dr Raje
00:23:33Utility of Antibody-Drug Conjugates for Relapsed/Refractory (R/R) MM — Dr Orlowski
00:41:12Potential Role of Cereblon E3 Ligase Modulators and Other Promising Novel Agents and Strategies for R/R MM — Prof Dimopoulos

TRANSCRIÇÃO 🔗

Are you the producer of this podcast? Add a podcast transcript
Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

PESQUISAR EPISÓDIOS PASSADOS

Pesquisar episódios anteriores de Hematologic Oncology Update.
Incorpore esta barra de pesquisa ao seu site

OUTROS EPISÓDIOS NESTE PODCAST

Diffuse Large B-Cell Lymphoma — Proceedings from a Symposium Held in Conjunction with the American Oncology Network

Diffuse Large B-Cell Lymphoma — Proceedings from a Symposium Held in Conjunction with the American Oncology Network

Featuring perspectives from Dr Ann LaCasce and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics: Introduction (0:00) First-Line Treatment (1:33) Bispecific Antibodies and Chimeric Antigen Receptor T-Cell Therapy (20:36) CME information and select publications
00:50:22
PARTILHAR
GUARDAR
Chronic Lymphocytic Leukemia — Microlearning Activity 1

Chronic Lymphocytic Leukemia — Microlearning Activity 1

Featuring perspectives from Dr Catherine C Coombs, including the following topics: Early versus delayed addition of obinutuzumab to acalabrutinib and venetoclax in treatment-naïve chronic lymphocytic leukemia (CLL) (0:00) Feasibility of discontinuation of Bruton tyrosine kinase (BTK) inhibitor the…
00:24:32
PARTILHAR
GUARDAR
Chronic Lymphocytic Leukemia — Investigators Discuss Optimal Management

Chronic Lymphocytic Leukemia — Investigators Discuss Optimal Management

Featuring perspectives from Dr Catherine C Coombs and Dr Matthew S Davids, including the following topics: Introduction (0:00) Minimal Residual Disease Assays in Community-Based Practice (1:24) New Developments in Previously Untreated Chronic Lymphocytic Leukemia (CLL) — Dr Davids (8:12) Richter T…
00:58:15
PARTILHAR
GUARDAR
Diffuse Large B-Cell Lymphoma — An Interview with Dr L Elizabeth Budde on Employing CD20 x CD3 Bispecific Antibodies

Diffuse Large B-Cell Lymphoma — An Interview with Dr L Elizabeth Budde on Employing CD20 x CD3 Bispecific Antibodies

Featuring an interview with Dr L Elizabeth Budde, including the following topics: Considerations for selecting between bispecific antibodies (BsAbs); monotherapy versus combination therapy (0:00) Management of BsAb-induced cytokine release syndrome and other toxicities (7:35) Use of BsAbs in the f…
00:47:06
PARTILHAR
GUARDAR
Aviso: O podcast e a arte incorporada nesta página são de Dr. Neil Love, que é propriedade de seu proprietário e não é afiliado ou endossado por Listen Notes, Inc.
PROMOTED
The best Podcast API & MCP to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
The best Podcast API & MCP to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
PodcastAPI.com

RECOMENDAÇÕES
Use a API para ir buscar este episódio